These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25896643)

  • 1. [Levosimendan as a treatment for acute renal failure associated with cardiogenic shock after hip fracture].
    Hinojosa FQ; Revelo M; Salazar A; Maggi G; Schiraldi R; Brogly N; Gilsanz F
    Rev Bras Anestesiol; 2017; 67(1):89-91. PubMed ID: 25896643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan as a treatment for acute renal failure associated with cardiogenic shock after hip fracture.
    Hinojosa FQ; Revelo M; Salazar A; Maggi G; Schiraldi R; Brogly N; Gilsanz F
    Braz J Anesthesiol; 2017; 67(1):89-91. PubMed ID: 28017176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
    Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
    Pathak A; Lebrin M; Vaccaro A; Senard JM; Despas F
    J Clin Pharm Ther; 2013 Oct; 38(5):341-9. PubMed ID: 23594161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute heart failure: acute cardiogenic pulmonary edema and cardiogenic shock].
    Sánchez Marteles M; Urrutia A
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():14-9. PubMed ID: 24930078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
    Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS; Pollesello P; Vajda G; Papp Z
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe aortic stenosis and cardiogenic shock: a therapeutic challenge].
    Caetano F; Almeida I; Seca L; Botelho A; Mota P; Leitão Marques A
    Rev Port Cardiol; 2013 Sep; 32(9):701-6. PubMed ID: 23845722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
    Baysal A; Yanartas M; Dogukan M; Gundogus N; Kocak T; Koksal C
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):586-94. PubMed ID: 24447501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
    Rokyta R; Pechman V
    Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan in perioperative and critical care patients.
    Salmenperä M; Eriksson H
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):496-501. PubMed ID: 19502977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
    Dominguez-Rodriguez A; Samimi-Fard S; Garcia-Gonzalez MJ; Abreu-Gonzalez P
    Int J Cardiol; 2008 Aug; 128(2):214-7. PubMed ID: 17643535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan in cardiac failure after subarachnoid hemorrhage.
    Busani S; Rinaldi L; Severino C; Cobelli M; Pasetto A; Girardis M
    J Trauma; 2010 May; 68(5):E108-10. PubMed ID: 20453750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M; Pignataro C; Fraticelli A; Mebazaa A
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous levosimendan infusion for refractory cardiogenic shock complicating severe acute dichlorvos poisoning.
    Liu Y; Liu B; Zhou H; Wei LQ
    Am J Med Sci; 2012 Aug; 344(2):166-70. PubMed ID: 22771967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer approaches to the pharmacological management of heart failure.
    Rauch H; Motsch J; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):75-81. PubMed ID: 16547437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan for post-partum cardiomyopathy.
    Nguyen HD; McKeown B
    Crit Care Resusc; 2005 Jun; 7(2):107-10. PubMed ID: 16548802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.